AIDS nucleic acid (Shenzhen Yike Biopharmaceutical)

艾滋病核酸 (深圳医克生物医药)

Report date: 2026/04/16 20:00:17

Base Information

Drug NameAIDS nucleic acid (Shenzhen Yike Biopharmaceutical)
Drug Alias Name艾丝为克HIV Therapeutic DNA Vaccine (Shenzhen Yike Biopharmaceutical)ICVAXIMC-001
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong KongMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenzhen Yike Biopharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesImmuno Cure Holding (HK) LtdShenzhen Yike Biopharmaceutical Co LtdImmuno Cure BioTech Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A